Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.
LPI (LP Information)' newest research report, the "Insulin Delivery Devices Industry Forecast" looks at past sales and reviews total world Insulin Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Insulin Delivery Devices sales for 2023 through 2029. With Insulin Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Insulin Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Insulin Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin Delivery Devices.
The global Insulin Delivery Devices market size is projected to grow from US$ 10350 million in 2022 to US$ 13480 million in 2029; it is expected to grow at a CAGR of 13480 from 2023 to 2029.
In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Insulin Pens
- Insulin Pumps
- Insulin Syringes
- Others
Segmentation by application
- Patients/Homecare
- Hospitals & Clinics
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Animas
- Beta Bionics
- Cellnovo
- Copernicus
- Dance Biopharm
- Debiotech
- Insulet
- MannKind
- Owen Mumford
- Roche
- SOOIL
- Tandem Diabetes Care
- Valeritas
- West Pharma
- Ypsomed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insulin Delivery Devices market?
What factors are driving Insulin Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insulin Delivery Devices market opportunities vary by end market size?
How does Insulin Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global Insulin Delivery Devices Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Insulin Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Insulin Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Insulin Delivery Devices Segment by Type
2.2.1 Insulin Pens
2.2.2 Insulin Pumps
2.2.3 Insulin Syringes
2.2.4 Others
2.3 Insulin Delivery Devices Sales by Type
2.3.1 Global Insulin Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Insulin Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Insulin Delivery Devices Sale Price by Type (2018-2023)
2.4 Insulin Delivery Devices Segment by Application
2.4.1 Patients/Homecare
2.4.2 Hospitals & Clinics
2.5 Insulin Delivery Devices Sales by Application
2.5.1 Global Insulin Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Insulin Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Insulin Delivery Devices Sale Price by Application (2018-2023)
3 Global Insulin Delivery Devices by Company
3.1 Global Insulin Delivery Devices Breakdown Data by Company
3.1.1 Global Insulin Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Insulin Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Insulin Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Insulin Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Insulin Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Insulin Delivery Devices Sale Price by Company
3.4 Key Manufacturers Insulin Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Delivery Devices Product Location Distribution
3.4.2 Players Insulin Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin Delivery Devices by Geographic Region
4.1 World Historic Insulin Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Insulin Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Insulin Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Insulin Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Insulin Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Insulin Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Insulin Delivery Devices Sales Growth
4.4 APAC Insulin Delivery Devices Sales Growth
4.5 Europe Insulin Delivery Devices Sales Growth
4.6 Middle East & Africa Insulin Delivery Devices Sales Growth
5 Americas
5.1 Americas Insulin Delivery Devices Sales by Country
5.1.1 Americas Insulin Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Insulin Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Insulin Delivery Devices Sales by Type
5.3 Americas Insulin Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Delivery Devices Sales by Region
6.1.1 APAC Insulin Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Insulin Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Insulin Delivery Devices Sales by Type
6.3 APAC Insulin Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin Delivery Devices by Country
7.1.1 Europe Insulin Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Insulin Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Insulin Delivery Devices Sales by Type
7.3 Europe Insulin Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Delivery Devices by Country
8.1.1 Middle East & Africa Insulin Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Insulin Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Insulin Delivery Devices Sales by Type
8.3 Middle East & Africa Insulin Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Delivery Devices
10.3 Manufacturing Process Analysis of Insulin Delivery Devices
10.4 Industry Chain Structure of Insulin Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Delivery Devices Distributors
11.3 Insulin Delivery Devices Customer
12 World Forecast Review for Insulin Delivery Devices by Geographic Region
12.1 Global Insulin Delivery Devices Market Size Forecast by Region
12.1.1 Global Insulin Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Insulin Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Delivery Devices Forecast by Type
12.7 Global Insulin Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Insulin Delivery Devices Product Portfolios and Specifications
13.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Insulin Delivery Devices Product Portfolios and Specifications
13.2.3 Sanofi Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Insulin Delivery Devices Product Portfolios and Specifications
13.3.3 BD Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Insulin Delivery Devices Product Portfolios and Specifications
13.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Insulin Delivery Devices Product Portfolios and Specifications
13.5.3 Medtronic Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 Animas
13.6.1 Animas Company Information
13.6.2 Animas Insulin Delivery Devices Product Portfolios and Specifications
13.6.3 Animas Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Animas Main Business Overview
13.6.5 Animas Latest Developments
13.7 Beta Bionics
13.7.1 Beta Bionics Company Information
13.7.2 Beta Bionics Insulin Delivery Devices Product Portfolios and Specifications
13.7.3 Beta Bionics Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Beta Bionics Main Business Overview
13.7.5 Beta Bionics Latest Developments
13.8 Cellnovo
13.8.1 Cellnovo Company Information
13.8.2 Cellnovo Insulin Delivery Devices Product Portfolios and Specifications
13.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cellnovo Main Business Overview
13.8.5 Cellnovo Latest Developments
13.9 Copernicus
13.9.1 Copernicus Company Information
13.9.2 Copernicus Insulin Delivery Devices Product Portfolios and Specifications
13.9.3 Copernicus Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Copernicus Main Business Overview
13.9.5 Copernicus Latest Developments
13.10 Dance Biopharm
13.10.1 Dance Biopharm Company Information
13.10.2 Dance Biopharm Insulin Delivery Devices Product Portfolios and Specifications
13.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Dance Biopharm Main Business Overview
13.10.5 Dance Biopharm Latest Developments
13.11 Debiotech
13.11.1 Debiotech Company Information
13.11.2 Debiotech Insulin Delivery Devices Product Portfolios and Specifications
13.11.3 Debiotech Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Debiotech Main Business Overview
13.11.5 Debiotech Latest Developments
13.12 Insulet
13.12.1 Insulet Company Information
13.12.2 Insulet Insulin Delivery Devices Product Portfolios and Specifications
13.12.3 Insulet Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Insulet Main Business Overview
13.12.5 Insulet Latest Developments
13.13 MannKind
13.13.1 MannKind Company Information
13.13.2 MannKind Insulin Delivery Devices Product Portfolios and Specifications
13.13.3 MannKind Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MannKind Main Business Overview
13.13.5 MannKind Latest Developments
13.14 Owen Mumford
13.14.1 Owen Mumford Company Information
13.14.2 Owen Mumford Insulin Delivery Devices Product Portfolios and Specifications
13.14.3 Owen Mumford Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Owen Mumford Main Business Overview
13.14.5 Owen Mumford Latest Developments
13.15 Roche
13.15.1 Roche Company Information
13.15.2 Roche Insulin Delivery Devices Product Portfolios and Specifications
13.15.3 Roche Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Roche Main Business Overview
13.15.5 Roche Latest Developments
13.16 SOOIL
13.16.1 SOOIL Company Information
13.16.2 SOOIL Insulin Delivery Devices Product Portfolios and Specifications
13.16.3 SOOIL Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 SOOIL Main Business Overview
13.16.5 SOOIL Latest Developments
13.17 Tandem Diabetes Care
13.17.1 Tandem Diabetes Care Company Information
13.17.2 Tandem Diabetes Care Insulin Delivery Devices Product Portfolios and Specifications
13.17.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Tandem Diabetes Care Main Business Overview
13.17.5 Tandem Diabetes Care Latest Developments
13.18 Valeritas
13.18.1 Valeritas Company Information
13.18.2 Valeritas Insulin Delivery Devices Product Portfolios and Specifications
13.18.3 Valeritas Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Valeritas Main Business Overview
13.18.5 Valeritas Latest Developments
13.19 West Pharma
13.19.1 West Pharma Company Information
13.19.2 West Pharma Insulin Delivery Devices Product Portfolios and Specifications
13.19.3 West Pharma Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 West Pharma Main Business Overview
13.19.5 West Pharma Latest Developments
13.20 Ypsomed
13.20.1 Ypsomed Company Information
13.20.2 Ypsomed Insulin Delivery Devices Product Portfolios and Specifications
13.20.3 Ypsomed Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Ypsomed Main Business Overview
13.20.5 Ypsomed Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Insulin Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Insulin Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Insulin Pens
Table 4. Major Players of Insulin Pumps
Table 5. Major Players of Insulin Syringes
Table 6. Major Players of Others
Table 7. Global Insulin Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 8. Global Insulin Delivery Devices Sales Market Share by Type (2018-2023)
Table 9. Global Insulin Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 10. Global Insulin Delivery Devices Revenue Market Share by Type (2018-2023)
Table 11. Global Insulin Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Insulin Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 13. Global Insulin Delivery Devices Sales Market Share by Application (2018-2023)
Table 14. Global Insulin Delivery Devices Revenue by Application (2018-2023)
Table 15. Global Insulin Delivery Devices Revenue Market Share by Application (2018-2023)
Table 16. Global Insulin Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Insulin Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 18. Global Insulin Delivery Devices Sales Market Share by Company (2018-2023)
Table 19. Global Insulin Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Insulin Delivery Devices Revenue Market Share by Company (2018-2023)
Table 21. Global Insulin Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Insulin Delivery Devices Producing Area Distribution and Sales Area
Table 23. Players Insulin Delivery Devices Products Offered
Table 24. Insulin Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Insulin Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Insulin Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 29. Global Insulin Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Insulin Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Insulin Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Insulin Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 33. Global Insulin Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Insulin Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Insulin Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 36. Americas Insulin Delivery Devices Sales Market Share by Country (2018-2023)
Table 37. Americas Insulin Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Insulin Delivery Devices Revenue Market Share by Country (2018-2023)
Table 39. Americas Insulin Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 40. Americas Insulin Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 41. APAC Insulin Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 42. APAC Insulin Delivery Devices Sales Market Share by Region (2018-2023)
Table 43. APAC Insulin Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Insulin Delivery Devices Revenue Market Share by Region (2018-2023)
Table 45. APAC Insulin Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 46. APAC Insulin Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 47. Europe Insulin Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 48. Europe Insulin Delivery Devices Sales Market Share by Country (2018-2023)
Table 49. Europe Insulin Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Insulin Delivery Devices Revenue Market Share by Country (2018-2023)
Table 51. Europe Insulin Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 52. Europe Insulin Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Insulin Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Insulin Delivery Devices Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Insulin Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Insulin Delivery Devices Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Insulin Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Insulin Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Insulin Delivery Devices
Table 60. Key Market Challenges & Risks of Insulin Delivery Devices
Table 61. Key Industry Trends of Insulin Delivery Devices
Table 62. Insulin Delivery Devices Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Insulin Delivery Devices Distributors List
Table 65. Insulin Delivery Devices Customer List
Table 66. Global Insulin Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Insulin Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Insulin Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Insulin Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Insulin Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Insulin Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Insulin Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Insulin Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Insulin Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Insulin Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Insulin Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Insulin Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Insulin Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Insulin Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novo Nordisk Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 81. Novo Nordisk Insulin Delivery Devices Product Portfolios and Specifications
Table 82. Novo Nordisk Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Latest Developments
Table 85. Sanofi Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Insulin Delivery Devices Product Portfolios and Specifications
Table 87. Sanofi Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. BD Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. BD Insulin Delivery Devices Product Portfolios and Specifications
Table 92. BD Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. BD Main Business
Table 94. BD Latest Developments
Table 95. Eli Lilly Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. Eli Lilly Insulin Delivery Devices Product Portfolios and Specifications
Table 97. Eli Lilly Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Eli Lilly Main Business
Table 99. Eli Lilly Latest Developments
Table 100. Medtronic Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. Medtronic Insulin Delivery Devices Product Portfolios and Specifications
Table 102. Medtronic Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Medtronic Main Business
Table 104. Medtronic Latest Developments
Table 105. Animas Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Animas Insulin Delivery Devices Product Portfolios and Specifications
Table 107. Animas Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Animas Main Business
Table 109. Animas Latest Developments
Table 110. Beta Bionics Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. Beta Bionics Insulin Delivery Devices Product Portfolios and Specifications
Table 112. Beta Bionics Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Beta Bionics Main Business
Table 114. Beta Bionics Latest Developments
Table 115. Cellnovo Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 116. Cellnovo Insulin Delivery Devices Product Portfolios and Specifications
Table 117. Cellnovo Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Cellnovo Main Business
Table 119. Cellnovo Latest Developments
Table 120. Copernicus Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. Copernicus Insulin Delivery Devices Product Portfolios and Specifications
Table 122. Copernicus Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Copernicus Main Business
Table 124. Copernicus Latest Developments
Table 125. Dance Biopharm Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 126. Dance Biopharm Insulin Delivery Devices Product Portfolios and Specifications
Table 127. Dance Biopharm Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Dance Biopharm Main Business
Table 129. Dance Biopharm Latest Developments
Table 130. Debiotech Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 131. Debiotech Insulin Delivery Devices Product Portfolios and Specifications
Table 132. Debiotech Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Debiotech Main Business
Table 134. Debiotech Latest Developments
Table 135. Insulet Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 136. Insulet Insulin Delivery Devices Product Portfolios and Specifications
Table 137. Insulet Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Insulet Main Business
Table 139. Insulet Latest Developments
Table 140. MannKind Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 141. MannKind Insulin Delivery Devices Product Portfolios and Specifications
Table 142. MannKind Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. MannKind Main Business
Table 144. MannKind Latest Developments
Table 145. Owen Mumford Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 146. Owen Mumford Insulin Delivery Devices Product Portfolios and Specifications
Table 147. Owen Mumford Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Owen Mumford Main Business
Table 149. Owen Mumford Latest Developments
Table 150. Roche Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 151. Roche Insulin Delivery Devices Product Portfolios and Specifications
Table 152. Roche Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Roche Main Business
Table 154. Roche Latest Developments
Table 155. SOOIL Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 156. SOOIL Insulin Delivery Devices Product Portfolios and Specifications
Table 157. SOOIL Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. SOOIL Main Business
Table 159. SOOIL Latest Developments
Table 160. Tandem Diabetes Care Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 161. Tandem Diabetes Care Insulin Delivery Devices Product Portfolios and Specifications
Table 162. Tandem Diabetes Care Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Tandem Diabetes Care Main Business
Table 164. Tandem Diabetes Care Latest Developments
Table 165. Valeritas Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 166. Valeritas Insulin Delivery Devices Product Portfolios and Specifications
Table 167. Valeritas Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Valeritas Main Business
Table 169. Valeritas Latest Developments
Table 170. West Pharma Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 171. West Pharma Insulin Delivery Devices Product Portfolios and Specifications
Table 172. West Pharma Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 173. West Pharma Main Business
Table 174. West Pharma Latest Developments
Table 175. Ypsomed Basic Information, Insulin Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 176. Ypsomed Insulin Delivery Devices Product Portfolios and Specifications
Table 177. Ypsomed Insulin Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 178. Ypsomed Main Business
Table 179. Ypsomed Latest Developments
List of Figures
Figure 1. Picture of Insulin Delivery Devices
Figure 2. Insulin Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Insulin Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Insulin Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Insulin Pens
Figure 10. Product Picture of Insulin Pumps
Figure 11. Product Picture of Insulin Syringes
Figure 12. Product Picture of Others
Figure 13. Global Insulin Delivery Devices Sales Market Share by Type in 2022
Figure 14. Global Insulin Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 15. Insulin Delivery Devices Consumed in Patients/Homecare
Figure 16. Global Insulin Delivery Devices Market: Patients/Homecare (2018-2023) & (K Units)
Figure 17. Insulin Delivery Devices Consumed in Hospitals & Clinics
Figure 18. Global Insulin Delivery Devices Market: Hospitals & Clinics (2018-2023) & (K Units)
Figure 19. Global Insulin Delivery Devices Sales Market Share by Application (2022)
Figure 20. Global Insulin Delivery Devices Revenue Market Share by Application in 2022
Figure 21. Insulin Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 22. Global Insulin Delivery Devices Sales Market Share by Company in 2022
Figure 23. Insulin Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Insulin Delivery Devices Revenue Market Share by Company in 2022
Figure 25. Global Insulin Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Insulin Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Insulin Delivery Devices Sales 2018-2023 (K Units)
Figure 28. Americas Insulin Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 29. APAC Insulin Delivery Devices Sales 2018-2023 (K Units)
Figure 30. APAC Insulin Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 31. Europe Insulin Delivery Devices Sales 2018-2023 (K Units)
Figure 32. Europe Insulin Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Insulin Delivery Devices Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Insulin Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 35. Americas Insulin Delivery Devices Sales Market Share by Country in 2022
Figure 36. Americas Insulin Delivery Devices Revenue Market Share by Country in 2022
Figure 37. Americas Insulin Delivery Devices Sales Market Share by Type (2018-2023)
Figure 38. Americas Insulin Delivery Devices Sales Market Share by Application (2018-2023)
Figure 39. United States Insulin Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Insulin Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Insulin Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Insulin Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Insulin Delivery Devices Sales Market Share by Region in 2022
Figure 44. APAC
Global Non-Invasive Glucose Meter Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 79
This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma.
The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
Global Glucose Meter Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 106
Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
Global Blood Glucose Testing Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 101
Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes.
Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter.
A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
Global Glucose Biosensors Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 139
According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
Global Artificial Pancreas Devices Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period.
The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
Global Blood Glucose Testing Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 130
According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period.
The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
Global Lancing Devices Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 117
According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period.
The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
Global Non-Invasive Glucose Meter Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
Global Glucose Meter Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
